SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001663577-20-000196
Filing Date
2020-07-06
Accepted
2020-07-06 16:25:55
Documents
53
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 skvi10q.htm 10-Q 359350
2 GRAPHIC image_001.jpg GRAPHIC 8053
3 ex31_1.htm EX-31.1 9071
4 ex31_2.htm EX-31.2 8989
5 ex32_1.htm EX-32.1 4118
  Complete submission text file 0001663577-20-000196.txt   2222317

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE skvi-20200331.xml EX-101.INS 345086
7 XBRL SCHEMA FILE skvi-20200331.xsd EX-101.SCH 24181
8 XBRL CALCULATION FILE skvi-20200331_cal.xml EX-101.CAL 26509
9 XBRL DEFINITION FILE skvi-20200331_def.xml EX-101.DEF 68571
10 XBRL LABEL FILE skvi-20200331_lab.xml EX-101.LAB 184227
11 XBRL PRESENTATION FILE skvi-20200331_pre.xml EX-101.PRE 163848
Mailing Address 6320 S SANDHILL ROAD SUITE 10 LAS VEGAS NV 89120
Business Address 6320 S SANDHILL ROAD SUITE 10 LAS VEGAS NV 89120 7024337154
SKINVISIBLE, INC. (Filer) CIK: 0001085277 (see all company filings)

IRS No.: 880344219 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25911 | Film No.: 201013784
SIC: 2834 Pharmaceutical Preparations